An international, peer reviewed, open access journal focusing on molecular drug targets, including disease-specific proteins, receptors, enzymes, and genes, and on elucidation of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life.
Editor in Chief: Professor Anuj Chauhan
Processing Speed: High quality, constructive peer review and rapid editorial decision within an average of four weeks.
Sign up for email alerts to receive notifications of new articles published in Drug Target Insights
I have had contact with Drug Target Insights several times, and every time I am impressed by the handling of the manuscript. The website is very, very user-friendly. It is easy to submit a manuscript. The entire process is easy and straightforward. The corresponding author is kept updated on the progress at every point. The editors of Libertas were helpful and prompt in responding to questions and issues related to the submission I am pleased ...